Ionis Pharmaceuticals Files 2024 Annual Report

Ticker: IONS · Form: 10-K · Filed: Feb 19, 2025 · CIK: 874015

Sentiment: neutral

Topics: annual-report, pharmaceuticals, financials

TL;DR

IONIS 10-K is IN. Full year financials out, check for key updates.

AI Summary

Ionis Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, headquartered in Carlsbad, CA, reported on its financial performance and business operations. Key financial data and operational details are presented in this comprehensive annual report.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of Ionis Pharmaceuticals' financial health, strategic direction, and potential risks for the past fiscal year.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Ionis faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What were the total revenues for Ionis Pharmaceuticals in fiscal year 2024?

The filing indicates revenue streams such as 'CollaborativeAgreementRevenueMember' and 'WainusRoyaltiesMember' for the period ending 2024-12-31, but specific total revenue figures are not detailed in this excerpt.

What is the company's primary business address?

The company's business address is 2855 GAZELLE COURT, CARLSBAD, CA 92010.

When was the company formerly known as ISIS PHARMACEUTICALS INC?

The name change from ISIS PHARMACEUTICALS INC to IONIS PHARMACEUTICALS INC occurred on 19930328.

What are the different types of convertible senior notes mentioned?

The filing mentions 'ConvertibleSeniorNotes0PercentMember', 'ConvertibleSeniorNotes175PercentMember', and 'ConvertibleSeniorNotes0125PercentMember'.

What is the SIC code for Ionis Pharmaceuticals?

The Standard Industrial Classification (SIC) code for Ionis Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 19, 2025 regarding IONIS PHARMACEUTICALS INC (IONS).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing